Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details)

Stockholders’ Equity (Details) - USD ($)
1 Months Ended 3 Months Ended
Oct. 07, 2020
Jan. 31, 2018
Oct. 31, 2022
Oct. 31, 2021
Jul. 31, 2022
Sep. 30, 2017
Jan. 31, 2011
Stockholders’ Equity (Details) [Line Items]              
Common stock, par value (in Dollars per share)     $ 0.01   $ 0.01    
Percentage of commission payable on equity offering     3.00%        
Common stock available for grant, description The amendment and restatement of the Amended and Restated 2011 Plan was for purposes of, among other things, (i) increasing the shares of common stock available for grant under the Amended and Restated 2011 Plan by an additional 4,000,000 shares of common stock bringing the total number of shares available for grant to 9,000,000 shares of common stock and (ii) extending the term of the Amended and Restated 2011 Plan until October 7, 2030.            
Common stock granted (in Shares)     4,357,000        
Total future compensation cost     $ 1,997        
Weighted average remaining life of approximately     2 years        
Remaining PSUs awarded Expired     3 years        
Performance share, description     During the fiscal years ended 2020 and 2019, the Company awarded additional PSUs to its executive officers. These awards provide for the grant of shares of our common stock at the end of a three-year period based on the achievement of revenue growth and adjusted EBITDA growth goals met at threshold, target or maximum levels over the respective period. The PSUs awarded to executive officers in fiscal 2019, net of forfeitures, were earned as of the three-year period ending July 31, 2022 as the growth goals at the maximum level were achieved. After TSR modification, a total of 25,200 PSUs were earned equally by two officers. The shares will be issued in the second quarter of fiscal 2023. During the three months ended October 31, 2022 a former officer forfeited 15,000 PSUs awarded in fiscal 2020, and the Company reversed PSU accruals of $55 related to the fiscal 2020 awards. During the three months ended October 31, 2021 the Company accrued PSU compensation expense of $66.         
Shared based compensation expense     $ 186,000 $ 0      
Unrecognized compensation     $ 1,295,000        
2011 Plan [Member]              
Stockholders’ Equity (Details) [Line Items]              
Share based compensation arrangement by share based payment award restricted stock units (in Shares)             3,000,000
Share-based compensation arrangement by share-based payment award, number of additional shares authorized (in Shares)   2,000,000          
Common stock available for grants (in Shares)   5,000,000          
Common Stock [Member]              
Stockholders’ Equity (Details) [Line Items]              
Authorized common stock that may be issued and sold under sales agreement           $ 19,200,000